EVALUATION OF LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB THERAPY IN PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME: RESULTS FROM BETA-CONFIDENT REGISTRY

被引：0
|
作者：
Kuemmerle-Deschner, J. [1 ]
Hoffman, H. [2 ]
Hawkins, P. [3 ]
van der Poll, T. [4 ]
Walker, U. [5 ]
Speziale, A. [6 ]
Tilson, H. [7 ]
机构：
[1] Univ Hosp Tuebingen, Tubingen, Germany
[2] Univ Calif San Diego, La Jolla, CA 92093 USA
[3] UCL, Sch Med, London, England
[4] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands
[5] Univ Hosp, Basel, Switzerland
[6] Novartis Pharma AG, Basel, Switzerland
[7] Univ N Carolina, Chapel Hill, NC USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.2224
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0524
引用
收藏
页码：850 / 850
页数：1
相关论文
共 50 条
  • [31] EFFICACY AND SAFETY OF CANAKINUMAB IN A LARGE COHORT OF PATIENTS ACROSS DIFFERENT SEVERITY PHENOTYPES OF CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME (CAPS)
    Lachmann, H. J.
    Kuemmerle-Deschner, J. B.
    Hachulla, E.
    Kone-Paut, I
    Hoyer, J.
    Smith, J.
    Leslie, K.
    Patel, N.
    Preiss, R.
    Hawkins, P. N.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S93 - S93
  • [32] Efficacy and Safety of Canakinumab in a Large Cohort of Cryopyrin-Associated Periodic Syndrome (CAPS) Patients across All Severity Phenotypes
    Cartwright, R.
    Smith, J.
    Hawkins, P.
    Kuemmerle-Deschner, J.
    Hachulla, E.
    Kone-Paut, I.
    Hoyer, J.
    Quartier, P.
    Gattorno, M.
    Widmer, A.
    Patel, N.
    Preiss, R.
    Leslie, K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB226 - AB226
  • [33] Real-World Experience and Impact of Canakinumab in Cryopyrin-Associated Periodic Syndrome: Results From a French Observational Study
    Kone-Paut, I.
    Quartier, P.
    Fain, O.
    Grateau, G.
    Pillet, P.
    Le Blay, P.
    Bonnet, F.
    Despert, V.
    Stankovic-Stojanovic, K.
    Willemin, L.
    Quere, S.
    Reigneau, O.
    Hachulla, E.
    ARTHRITIS CARE & RESEARCH, 2017, 69 (06) : 903 - 911
  • [34] Long-term renal outcome of Cryopyrin-associated periodic syndrome (CAPS) under anti-Interleukin-1 therapy
    Russwurm, Martin
    Johannsen, Sophia
    Kortus-Goetze, Birgit
    Haas, Christian S.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [35] Efficacy and Safety of Canakinumab in Patients with Cryopyrin Associated Periodic Syndrome: Results From Meta-Analysis of 5 Studies
    Lachmann, Helen J.
    Kuemmerle-Deschner, Jasmin B.
    Heike, Toshio
    Hara, Toshiro
    Yokota, Shumpei
    Mckernan, Phil
    Widmer, Albert
    Davis, Nicole
    Hachulla, Eric
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S321 - S322
  • [36] 3-years Safety and Efficacy Outcomes of Canakinumab Treatment in Cryopyrin-associated Periodic Syndromes (CAPS) - Data from the RELIANCE Registry
    Kuemmerle-Deschner, Jasmin B.
    Kortus-Goetze, Birgit
    Oommen, Prasad T.
    Janda, Ales
    Rech, Juergen
    Schuetz, Catharina
    Kallinich, Tilmann
    Weller-Heinemann, Frank
    Horneff, Gerd
    Foeldvari, Ivan
    Meier, Florian
    Borte, Michael
    Krickau, Tobias
    Weber-Arden, Julia
    Blank, Norbert
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1613 - 1614
  • [37] Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry
    Levy, R.
    Gerard, L.
    Kuemmerle-Deschner, J.
    Lachmann, H. J.
    Kone-Paut, I.
    Cantarini, L.
    Woo, P.
    Naselli, A.
    Bader-Meunier, B.
    Insalaco, A.
    AI-Mayoutl, S. M.
    Ozen, S.
    Hofer, M.
    Frenkel, J.
    Modesto, C.
    Nikishina, I.
    Schwarz, T.
    Martino, S.
    Meini, A.
    Quartier, P.
    Martini, A.
    Ruperto, N.
    Neven, B.
    Gattorno, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (11) : 2043 - 2049
  • [38] Long-term remission of cryopyrin-associated periodic syndrome after allogeneic haematopoietic stem cell transplantation
    Mori, Takehiko
    Saburi, Masuho
    Hagihara, Maki
    Mori, Masaaki
    Yamazaki, Rie
    Kato, Jun
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (04) : 542 - +
  • [39] Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Henes, Joerg
    Kortus-Goetze, Birgit
    Oommen, Prasad T.
    Rech, Juergen
    Krickau, Tobias
    Weller-Heinemann, Frank
    Horneff, Gerd
    Janda, Ales
    Foeldvari, Ivan
    Schuetz, Catharina
    Dressler, Frank
    Borte, Michael
    Hufnagel, Markus
    Meier, Florian
    Fiene, Michael
    Andreica, Ioana
    Weber-Arden, Julia
    Blank, Norbert
    RMD OPEN, 2024, 10 (01):
  • [40] Long-term safety of rilonacept (IL-1 trap) in cryopyrin-associated periodic syndromes (CAPS): Results from a 1-year study
    Hoffman, H.
    Grimes, I
    Weinstein, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (02) : 205 - 206
12345